Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma
NCT04200755
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Localized Scleroderma
Interventions
DRUG:
Dupilumab 300Mg Solution for Injection
OTHER:
Placebo
Sponsor
University of Cologne